These papers may be of use during viva discussions - they are grouped according to their subject.
Haemato-oncology
General/transfusion
Coagulation
ROCKET-AF trial
EINSTEIN-PE trial
REALIGN trial
Rivaroxaban vs warfarin in AF; non inferiority study with lower risk of intracranial haemorrhage, outcome points at 12-24 months
Comparison of rivaroxaban vs enoxaparin and vitK antagonist, randomised and controlled... Outcome of non inferiority and possibly superior outcomes of major bleeding events
Dabigatran vs warfarin in metallic valves: trial stopped early as 5% in dabigatran arm developed ischaemic stroke vs those who had warfarin (0%). Outcome data at three months